This $155,140 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) is funding research at Rutgers, The State University of New Jersey to explore the relationships between substance use disorders (SUDs) and other forms of psychopathology. The overarching goals are to improve classification and prediction of treatment response for SUDs by better understanding the phenotypic and genetic connections between SUDs and co-occurring psychiatric conditions. Key research activities include modeling the overlap between SUDs and other psychopathologies, identifying relevant genetic variants, and assessing the clinical utility of these insights. This award is part of a broader NIH initiative supporting a range of biomedical, behavioral, and epidemiological research to develop new knowledge and approaches for preventing, diagnosing, and treating substance use disorders.
Generated 3/4/25, 6:03 AM